Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality.
about
Devices in the management of advanced, chronic heart failureThe Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary resultsCatheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure.Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support.The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates.Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence.Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.Mechanical circulatory support.Predictors of right ventricular failure after left ventricular assist device implantation.Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist deviceDecision tree for adjuvant right ventricular support in patients receiving a left ventricular assist device.Which patients first? Planning the first clinical trial of xenotransplantation: a case for cardiac bridging.Right ventricular failure after left ventricular assist device implantation: the need for an implantable right ventricular assist device.Extracorporeal life support prior to left ventricular assist device implantation leads to improvement of the patients INTERMACS levels and outcome.Current status of mechanical circulatory assistance.New strategies for surgical management of ischemic cardiomyopathy.Lung perfusion and ventilation during implantation of left ventricular assist device as a strategy to avoid postoperative pulmonary complications and right ventricular failure.Can the temporary use of right ventricular assist devices bridge patients with acute right ventricular failure after cardiac surgery to recovery?Assessment of right ventricular function in left ventricular assist device candidates.Right heart failure post left ventricular assist device implantation.Pharmacotherapy for mechanical circulatory support: a comprehensive review.Management of right ventricular failure in the era of ventricular assist device therapy.Cardiogenic shock in ACS. Part 2: Role of mechanical circulatory support.Preoperative evaluation and perioperative management of right ventricular failure after left ventricular assist device implantation.Current status of mechanical circulatory support for treatment of advanced end-stage heart failure: successes, shortcomings and needs.Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices.A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy.Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation.Management of Right Ventricular Failure in Pulmonary Hypertension (and After LVAD Implantation).The risk of right ventricular failure with current continuous-flow left ventricular assist devices.Neurohumoral and inflammatory markers for prediction of right ventricular failure after implantation of a left ventricular assist device.Right ventricular assist device with membrane oxygenator support for right ventricular failure following implantable left ventricular assist device placement.
P2860
Q24630052-831BE034-9CC7-4D22-8091-9B0BCFA79D5FQ30359726-895DAF34-3856-4E1D-8610-669350CAAE9FQ33163104-CE564A6B-DC5D-468D-A2A5-50BDAFC8E5D2Q33390013-6C8AB5B1-558B-4BC0-8E3F-3159211EE21FQ33743667-0BFA9AF2-ACB0-4397-94F6-21EFC277BD1BQ33951341-C67390CF-1127-433F-8E2E-EFD2D09EB019Q33951353-9FCAD8D7-7232-4EBC-A07E-12E625BC05E3Q34852494-0371DB43-545F-43AE-914F-841DDACB56C3Q34965572-D08E1697-FD7D-4304-9E1D-9DF9463DDB12Q35559191-53FD65B5-CE1A-40C2-AE4E-91FBD4D7B141Q35597572-948A3A0A-78D1-439D-98E2-C705F6891B5CQ35740014-B2E6311F-E156-47EA-8F43-9B4AD1B72AA0Q36088303-89BE0597-0F7D-43AD-8217-527C8B48C8F0Q36107930-AF3A8249-2A9F-4371-897C-12B943C69C7AQ36328247-1EB5B135-2350-4865-94D2-A01F37A4EE8BQ36915732-4EB5B150-A368-438A-88FB-4A71F856AE83Q37134492-66A16D3C-B991-4845-9E6A-C5DCA842ABF0Q37247399-FF35A2C2-FB57-49FB-840E-39AC510E6465Q37642711-AC705875-5839-4265-A9E1-66C7EB5699B6Q37653938-F30504E5-1514-46F6-82FE-040C45149795Q37663891-7D52501C-3BB6-4742-8ACB-34A8D0452C8FQ37826020-3AA3BD74-EC80-485F-9623-A9E69542B3EEQ37827439-34F46821-269C-4D21-9B7B-61B074FC7BD2Q37974559-CD2A7F7A-C741-4CF0-9413-A62ACF96CA89Q38103758-73367520-641F-4E6A-B336-5770D62B67E0Q38870760-BAC14ED9-83C0-40A0-8FE0-9FF569FCD3FAQ40242112-B03E8C7D-8059-4FDB-9163-48B0F3039ACCQ40723481-CC72C8CD-F0D6-4CA5-A193-314D80E1FD27Q40930228-6A0250AC-6C44-496E-92B4-41564FF3A6BFQ41725903-5810A993-F348-4FE0-BCA7-001872358C7DQ46862794-79D4D0BF-1E43-4FD5-B76C-6BBEC991C537Q47316522-B7AE3869-F0E0-4574-ADA7-949689DED57FQ52899335-64CD20FD-5BCC-4C50-A4F4-365FBA7BD0E9Q53261891-2734955E-5449-4E47-8EDF-0AAC368397C0
P2860
Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Is severe right ventricular fa ...... and post-transplant mortality.
@ast
Is severe right ventricular fa ...... and post-transplant mortality.
@en
type
label
Is severe right ventricular fa ...... and post-transplant mortality.
@ast
Is severe right ventricular fa ...... and post-transplant mortality.
@en
prefLabel
Is severe right ventricular fa ...... and post-transplant mortality.
@ast
Is severe right ventricular fa ...... and post-transplant mortality.
@en
P2093
P1476
Is severe right ventricular fa ...... and post-transplant mortality.
@en
P2093
Brian J Lee
Jeffrey A Morgan
Mehmet C Oz
Ranjit John
Yoshifumi Naka
P304
P356
10.1016/J.ATHORACSUR.2003.09.048
P407
P577
2004-03-01T00:00:00Z